Peter Verdult

Stock Analyst at Citigroup

(n/a)
# 4,632
Out of 4,918 analysts
5
Total ratings
n/a
Success rate
-25.76%
Average return

Stocks Rated by Peter Verdult

Eli Lilly and Company
Jan 28, 2025
Maintains: Buy
Price Target: $1,250$1,190
Current: $762.33
Upside: +56.10%
Evotec SE
Jun 8, 2023
Upgrades: Buy
Price Target: n/a
Current: $4.00
Upside: -
Galapagos NV
Jan 27, 2022
Upgrades: Buy
Price Target: n/a
Current: $32.69
Upside: -